Lopinavir plus nucleoside reverse-transcriptase inhibitors, lopinavir plus raltegravir, or lopinavir monotherapy for second-line treatment of HIV (EARNEST): 144-week follow-up results from a…

Overview of attention for article published in Lancet Infectious Diseases, November 2017

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (96th percentile)
Good Attention Score compared to outputs of the same age and source (79th percentile)

Mentioned by

news: 7 news outlets
blogs: 1 blog

twitter: 23 X users

Citations

dimensions_citation: 34 Dimensions

Readers on

mendeley: 231 Mendeley

Summary News Blogs X Dimensions citations

So far, Altmetric has seen 1 blog post.

Sarah Walker

Department of Primary Care Health Sciences, 18 Jun 2019

This page shows the most recent blog posts that mention this research output.

Click here to find out how to access more activity.